National list of essential medicines

NLEM, Version 2562    [PDF]

Drug จ2

Docetaxel_Breast    [PDF]

Docetaxel_NSLC    [PDF]

Docetaxel_Prostate    [PDF]

Imatinib_GIST    [PDF]

Letrozole_Breast    [PDF]

NHSO Protocol

Protocol NHSO All, Version 2556    [PDF]

Protocol NHSO All, Version 2561    [PDF]

Protocol Bladder, Version 2561    [PDF]

Protocol Breast, Version 2561    [PDF]

Protocol Cervix, Version 2561    [PDF]

Protocol Colon-rectum, Version 2561    [PDF]

Protocol Esophagus, Version 2561    [PDF]

Protocol Liver, Version 2561    [PDF]

Protocol Lung, Version 2561    [PDF]

Protocol Nasopharynx, Version 2561    [PDF]

Protocol Ovary, Version 2561    [PDF]

Protocol Prostate, Version 2561    [PDF]

Protocol Stomach, Version 2561    [PDF]

Protocol Uterine, Version 2561    [PDF]

Protocol Osteosarcoma, Version 2561    [PDF]

Protocol Pediatric Cancer, Version 2561    [PDF]

NHSO Drug Registration Form

Trastuzumab, Version 2558    [PDF]

OCPA Protocol

Protocol OCPA All, Version 2549    [PDF]

Announcement ว34, 19/01/2561    [PDF]

      Bevacizumab_Colorectal    [PDF]

      Gefitinib_NSCLC    [PDF]

      Imatinib_GIST    [PDF]

      Sunitinib_GIST    [PDF]

      Trastuzumab_Breast    [PDF]

Announcement ว424, 20/09/2561    [PDF]

      Abiraterone acetate_Prostate    [PDF]

      Enzalutamide_Prostate    [PDF]

      Aprepitant-Palonosetron    [PDF]

      Bevacizumab_Colorectal (Revised)    [PDF]

      Bevacizumab_Ovary    [PDF]

      Ceritinib_NSCLC    [PDF]

      Panitumumab_Colorectal    [PDF]

      Pazopanib_RCC    [PDF]

      Pazopanib_Sarcoma    [PDF]

Announcement ว85, 22/02/2562    [PDF]

      Osimertinib_NSCLC    [PDF]

      Sorafenib_HCC    [PDF]

      Sorafenib_Thyroid    [PDF]

Announcement ว340, 12/07/2562    [PDF]

      Atezolizumab_NSCLC    [PDF]

      Ribociclib_Breast    [PDF]

Announcement ว532, 12/11/2562    [PDF]

      Trastuzumab_Breast    [PDF]

Announcement ว278, 19/06/2563    [PDF]

      Pertuzumab_Breast    [PDF]

OCPA Drug Registration Form

Abiraterone, Initiation, Version 20/09/2561    [PDF]

Abiraterone, Continuation, Version 20/09/2561    [PDF]

Alectinib, Initiation, Version 20/09/2561    [PDF]

Alectinib, Continuation, Version 20/09/2561    [PDF]

Atezolizumab, Initiation, Version 20/09/2561    [PDF]

Atezolizumab, Continuation, Version 20/09/2561    [PDF]

Barthel ADL, Version 19/01/2561    [PDF]

Bevacizumab, Initiation, Version 19/01/2561    [PDF]

Bevacizumab, Continuation, Version 19/01/2561    [PDF]

Bevacizumab_Ovary, Initiation, Version 19/01/2561    [PDF]

Bevacizumab_Ovary, Continuation, Version 19/01/2561    [PDF]

Ceritinib, Initiation, Version 20/09/2561    [PDF]

Ceritinib, Continuation, Version 20/09/2561    [PDF]

Cetuximab, Initiation, Version 20/09/2561    [PDF]

Crizotinib, Initiation, Version 20/09/2561    [PDF]

Crizotinib, Continuation, Version 20/09/2561    [PDF]

Enzalutamide, Initiation, Version 20/09/2561    [PDF]

Enzalutamide, Continuation, Version 20/09/2561    [PDF]

Gefitinib, Initiation, Version 19/01/2561    [PDF]

Gefitinib, Continuation, Version 19/01/2561    [PDF]

Imatinib, Initiation, Version 19/01/2561    [PDF]

Imatinib, Continuation, Version 19/01/2561    [PDF]

Lenvatinib, Initiation, Version 22/02/2562    [PDF]

Lenvatinib, Continuation, Version 22/02/2562    [PDF]

Osimertinib, Initiation, Version 22/02/2562    [PDF]

Osimertinib, Continuation, Version 22/02/2562    [PDF]

Palbociclib, Initiation, Version 20/09/2561    [PDF]

Palbociclib, Continuation, Version 20/09/2561    [PDF]

Panitumumab, Initiation, Version 20/09/2561    [PDF]

Panitumumab, Continuation, Version 20/09/2561    [PDF]

Pazopanib_RCC, Initiation, Version 20/09/2561    [PDF]

Pazopanib_RCC, Continuation, Version 20/09/2561    [PDF]

Pazopanib_Sarcoma, Initiation, Version 20/09/2561    [PDF]

Pazopanib_Sarcoma, Continuation, Version 20/09/2561    [PDF]

Ribociclib, Initiation, Version 20/09/2561    [PDF]

Ribociclib, Continuation, Version 20/09/2561    [PDF]

Sorafenib_HCC, Initiation, Version 22/02/2562    [PDF]

Sorafenib_HCC, Continuation, Version 22/02/2562    [PDF]

Sorafenib_Thyroid, Initiation, Version 22/02/2562    [PDF]

Sorafenib_Thyroid, Continuation, Version 22/02/2562    [PDF]

Sunitinib, Initiation, Version 19/01/2561    [PDF]

Sunitinib, Continuation, Version 19/01/2561    [PDF]

Trastuzumab Early, Initiation, Version 19/01/2561    [PDF]

Trastuzumab Early, Continuation, Version 19/01/2561    [PDF]

Trastuzumab Metastasis, Initiation, Version 19/01/2561    [PDF]

Trastuzumab metastasis, Continuation, Version 19/01/2561    [PDF]

Drug Termination, Version 19/01/2561    [PDF]